01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
After winning the World Cup on Sunday with a thrilling 2-0 victory over the Netherlands, the U.S. wo...
Read More >
It is fairly easy for a plaintiff to get conditional certification in a FLSA class action case, but ...
Read More >
On the latest episode of Williams Mullen's Benefits Companion, Marie Yascko-Rosado and Brydon DeWitt...
Read More >
State and local governments throughout the country continue to issue orders in response to the novel...
Read More >
In the 2019 session, the Minnesota Legislature introduced a number of sweeping changes to statutes a...
Read More >
The Evaluation of Corporate Compliance Programs, 2019 Guidance, makes clear that operationalization ...
Read More >